Related Experiment Video

Updated: Jun 19, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

No association between a promoter NOS1 polymorphism (rs41279104) and Infantile Hypertrophic Pyloric Stenosis

Kristina Lagerstedt-Robinson1, Anna Svenningsson, Agneta Nordenskjöld

  • 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. kristina.lagerstedt@ki.se

Journal of Human Genetics
|October 24, 2009
PubMed

Insights

This study investigated a specific gene variant (rs41279104) in infantile hypertrophic pyloric stenosis (IHPS). The research found no association between this genetic marker and the condition in familial or sporadic cases.

Area of Science:

  • Pediatric Surgery
  • Medical Genetics
  • Gastroenterology

Background:

  • Infantile hypertrophic pyloric stenosis (IHPS) is a congenital condition causing gastric outlet obstruction in infants.
  • The exact etiology of IHPS remains unknown, with suspected genetic and environmental contributions.
  • Previous research identified a potential association between a nitric oxide synthase gene (NOS1) polymorphism (rs41279104) and IHPS in a small patient cohort.

Purpose of the Study:

  • To investigate the association of the NOS1 promoter single nucleotide polymorphism (rs41279104) with infantile hypertrophic pyloric stenosis (IHPS).
  • To validate or refute the previously reported link between this specific SNP and IHPS in a larger cohort, including familial and sporadic cases.

Main Methods:

  • Case-control study design comparing IHPS patients (familial and sporadic) with healthy controls.
  • Genotyping of the NOS1 rs41279104 single nucleotide polymorphism.
  • Statistical analysis using univariate and multiple logistic regression models to assess the association.

Main Results:

  • The study analyzed 54 familial and 28 sporadic cases of IHPS.
  • No statistically significant association was found between the rs41279104 polymorphism in the NOS1 gene and infantile hypertrophic pyloric stenosis.
  • The findings did not replicate the previously suggested link between this SNP and IHPS.

Conclusions:

  • The investigated single nucleotide polymorphism (rs41279104) in the NOS1 gene promoter is not significantly associated with infantile hypertrophic pyloric stenosis (IHPS).
  • Further research is needed to elucidate the genetic underpinnings of IHPS, as this specific SNP does not appear to be a contributing factor.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...